Tristel plc
(“Tristel” or the “Company”)
Conference attendance at Mello2026 Investor event
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting and exhibiting at the Mello2026 investor event on Wednesday 18 November, which will be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY.
Chris Lee, CEO, and Anna Wasyl, CFO, will be presenting at 9:00am and 13:50pm on the day, providing an overview of the Company and strategy. No new information will be disclosed at the event, and a PDF of the presentation will be made available on the Company’s website at https://investors.tristel.com/investor-hub/.
For further information and tickets for the Mello2026 conference, please visit the event website at https://www.melloevents.com/mellolondon2026.
For further information please contact:
Tristel plc | Via Walbrook PR | |||
Chris Lee, Chief Executive Officer Anna Wasyl, Chief Financial Officer | ||||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |||
Paul McManus / Anna Dunphy / Rachel Broad | Mob: 07980 541 893/ 07876 741 001 / 07747 515 393 | |||
Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | |||
Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) | ||||
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | ||||
About Tristel plc
Tristel plc is a global infection prevention company focused on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre-wetted plastic wipe.
Tristel’s head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 280 people across 16 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an adjusted EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange’s AIM market since 2005 (AIM: TSTL).
For more information about Tristel’s product range please visit: https://tristel.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.